Data / Form D filings / Proteocyte Diagnostics Inc.
Proteocyte Diagnostics Inc.: Form D filings
Proteocyte Diagnostics Inc., a biotechnology company in Toronto, Ontario, Canada, filed 2 Form D notices with the SEC in 2023. The latest, on December 18, 2023, reports $36,925 sold of a $36,925 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- MARS CENTRE, SOUTH TOWER, 101 COLLEGE STREET, SUITE 200, Toronto, Ontario, Canada, M5G 1
- Phone
- (647) 255-1370
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Ontario, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1987946
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 18, 2023 | New notice | $36,925 | $36,925 | 1 | Dec 4, 2023 | sec.gov | |
| Jul 31, 2023 | New notice | $37,915 | $37,915 | 1 | Jul 17, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Steven Arless | Director | |
| John Jordan | Executive Officer, Director | |
| Barrie Renick | Director | |
| Anthony Morlandt | Director | |
| Carlo Sistilli | Director | |
| Mark Hammer | Executive Officer |
Every Form D from the week of Dec 18, 2023 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Proteocyte Diagnostics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.